Cargando…
Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer
Autores principales: | Untaru, Rossana, Chen, Dongqing, Kelly, Conagh, May, Austin, Collins, Nicholas J., Leitch, James, Attia, John R., Proeitto, Anthony M., Boyle, Andrew J., Sverdlov, Aaron L., Ngo, Doan T.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352161/ https://www.ncbi.nlm.nih.gov/pubmed/34396237 http://dx.doi.org/10.1016/j.jaccao.2020.05.010 |
Ejemplares similares
-
Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023) -
Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function
por: Kelly, Conagh J., et al.
Publicado: (2023) -
Overexpression of Mitochondrial Catalase within Adipose Tissue Does Not Confer Systemic Metabolic Protection against Diet-Induced Obesity
por: Croft, Amanda J., et al.
Publicado: (2023) -
Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiences
por: White, Jennifer, et al.
Publicado: (2022) -
Examining real world quality of care for Australia’s First Peoples presenting with chest pain
por: Williams, Trent D., et al.
Publicado: (2023)